GSA CAPITAL PARTNERS LLP - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 86 filers reported holding SEELOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$57
-19.7%
48,018
-54.3%
0.01%
-33.3%
Q4 2022$71
-99.9%
105,050
-23.5%
0.01%
-52.6%
Q3 2022$141,000
+642.1%
137,266
+398.4%
0.02%
+533.3%
Q2 2022$19,000
-90.3%
27,541
-66.0%
0.00%
-85.0%
Q3 2021$195,000
+387.5%
80,998
+216.9%
0.02%
+185.7%
Q4 2020$40,000
+53.8%
25,557
-6.9%
0.01%
+75.0%
Q3 2020$26,00027,4370.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,933,024$4,133,0000.30%
ACUTA CAPITAL PARTNERS, LLC 295,896$248,0000.12%
Connacht Asset Management LP 231,551$194,0000.10%
Uniplan Investment Counsel, Inc. 1,564,605$1,310,0000.08%
AdvisorShares Investments LLC 358,796$301,0000.05%
1492 Capital Management LLC 99,819$84,0000.04%
Woodline Partners LP 2,803,230$2,349,0000.04%
Ikarian Capital, LLC 257,883$215,0000.03%
Sovereign Financial Group, Inc. 75,000$63,0000.02%
Aquatic Capital Management LLC 6,400$5,0000.01%
View complete list of SEELOS THERAPEUTICS INC shareholders